| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| bluebird bio, Inc. | Chief Financial Officer | Common Stock | 45.5K | $65K | $1.43 | 06 Dec 2023 | Direct |
| bluebird bio, Inc. | Chief Financial Officer | Stock Option (right to buy) | 199K | 01 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EGRX | EAGLE PHARMACEUTICALS, INC. | 11 Nov 2024 | 0 | $0 | 3 | Chief Financial Officer | 19 Nov 2024, 19:59 |
| BLUE | bluebird bio, Inc. | 01 Mar 2024 | 1 | $0 | 4 | Chief Financial Officer | 05 Mar 2024, 17:39 |
| BLUE | bluebird bio, Inc. | 06 Dec 2023 | 1 | -$20.4K | 4 | Chief Financial Officer | 08 Dec 2023, 16:42 |
| BLUE | bluebird bio, Inc. | 01 Dec 2022 | 2 | $0 | 4 | Chief Financial Officer | 05 Dec 2022, 15:49 |
| BLUE | bluebird bio, Inc. | 07 Nov 2022 | 0 | $0 | 3 | Chief Financial Officer | 07 Nov 2022, 16:03 |